On February 11, 2015, cardiac arrhythmia health care professionals around the world will celebrate and be recognized for their unique knowledge and skillset during International Board of Heart Rhythm Examiners (IBHRE®) Day. IBHRE Day encourages employers to extend their appreciation to their IBHRE certified employees and offers a platform for the certified professionals to educate the public about their credentials.
Search for "" returned 981 matches
All the aspects of cardiac arrhythmias will be simultaneously reviewed by renowned leaders in the field of clinical arrhythmias, electrophysiology and cardiac pacing.
Today, in celebration of the International Board of Heart Rhythm Examiner’s (IBHRE) 30th anniversary in 2015, IBHRE has announced a new scholarship program for allied health care professionals seeking IBHRE certification.
This program is designed to provide electrophysiologists, cardiologists, cardiovascular surgeons, internists, and associated professionals with state-of-the-art information.
The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology.
Review approaches to catheter ablation, cardiac arrhythmias, AF ablation, atrial tachycardias, atypical flutters, and ventricular arrhythmias with or without associated heart disease.
This course is designed to provide the learner with the most up to date review of lead management.
This symposium will give an overview of how catheter ablation has rapidly evolved over the years.
For the first time, the relationship between remote monitoring and pacemaker patient survival outcomes is revealed in a study released today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions. The study shows that the utilization of remote monitoring can improve survival outcomes in patients with pacemakers. Furthermore, survival rates improved in patients with the highest engagement rates in remote monitoring, regardless of device type.
The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and American Heart Association (AHA) released Expert Consensus Statement on the Use of Implantable Cardioverter Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions. The expert consensus statement provides first-of-its-kind guidance on ICD therapy for the management of patient populations who are not well represented in clinical trials and, as a result, not specifically included in existing guidelines. View the consensus statement.